A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s
about
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s
description
im April 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 04 April 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2014
@uk
name
A phase II trial of intraperit ...... a gynecologic oncology group s
@en
A phase II trial of intraperit ...... a gynecologic oncology group s
@nl
type
label
A phase II trial of intraperit ...... a gynecologic oncology group s
@en
A phase II trial of intraperit ...... a gynecologic oncology group s
@nl
prefLabel
A phase II trial of intraperit ...... a gynecologic oncology group s
@en
A phase II trial of intraperit ...... a gynecologic oncology group s
@nl
P2093
P1433
P1476
A phase II trial of intraperit ...... necologic oncology group study
@en
P2093
Carolyn Y Muller
David P Bender
Michael W Sill
Robert L DeBernardo
Ronald D Alvarez
Susan A Davidson
Warner K Huh
P304
P356
10.1016/J.YGYNO.2014.03.571
P407
P577
2014-04-04T00:00:00Z